THC

SuzyCreamcheezies

At the risk of being pedantic, I would argue that high-regulation is unavoidable for federally legal cannabis anywhere. It carries too much of a stigma to be treated as casually as alcohol, not that I agree with it. At least it's becoming normalized in Canada, so perhaps we'll see looser regulations (bars and cafes?) in the future. I believe the illicit market is down about 80% since legalization, based solely on the abundance, cost and convenience of legal weed. Unless you mean the lax crackdown of grey market shops? Coincidentally, [Ontario just recently proposed](https://www.ctvnews.ca/toronto/article/ontario-is-proposing-a-crackdown-on-illegal-cannabis-stores-legal-retailers-say-it-is-long-overdue/) further crackdown on illegal shops. High taxes and low THC-edibles still suck.

Flipside68

It’s hard to stomach, high tax, high regulation, low THC dose (edibles), close to zero grey/illegal market crack down.

Ben_f157

Damn even THC is down

CJBlueNorther

Also nobody wants to serve a life sentence over having a THC pen on them.

GeoLogic23

I think finalizing hemp policy and finalizing cannabis rescheduling has to happen around the same time, so there can be one clear message about what is legal and what is not. It'd be so confusing to say "cannabis is schedule 3" right now and then say "hemp is completely banned" in a month. Because nobody knows the difference between hemp and marijuana to begin with. Would be much better to have an announcement where you could just say that CBD and low THC products are legal, while high THC products are still considered a scheduled drug. Instead of confusing everyone with hemp vs marijuana.

DasOmenGaming

You're correct, but OP does have some things to be mildly worried about. Dems did start the process, and blue states historically are more favorable to progressive policies in the Marijuana industry. But that doesn't directly translate to company value; Stock price is not a 1:1 measure of how accessible THC/CBD is. Few things to think about: * Dems 100% are more open to rescheduling/de-scheduling as a whole. But we are also more in favor of regulating industries, as a party as a whole. So the majorities in the House/Senate MAY (I say may, we will get to this in a moment), improve access to marijuana but it may also come with new expenses in the form of taxes, testing, regulations, etc. * Dem's have a majority in the House and Senate but not a super majority in the Senate. This means legislation is not filibuster proof. Dems would need 6 republicans (with the current projection of 54 Dem seats held) to cross the aisle and vote on an issue in the event that a filibuster is threatened/enacted on any legislation (which could very well be done by a republican senator that either A.) Hates marijuana reform or B.) Doesnt want the "Dems" to "steal" the reform from them). * Without a super majority, Trump can always veto anything the senate/house passes. So again, if he's spiteful and doesn't want the Dems to pass "his" reform, and there aren't 60+ (66?) votes of yes on it, then he can veto the bill * Hemp is also a threat. Some companies are doing both. But many companies are primarily, or all, in on Delta 8. Delta 9 is still an unknown wildcard which can impact the value of companies that are not commercializing it. Conversely, the uncertainty of its future legal status is a risk for companies that DO commercialize it. That said, we aren't necessarily worse off. I truly believe last nights election results will be favorable for overall growth within the industry, and company value. It may just be a bit bumpy for a bit.

Own-Recipe5908

Remember, red guys scheduled the ban on synthetic THC products they passed with the BBB to go in effect on november 12th (To avoid blowback). Just if you're thinking that investing in that type of thing is wise

Swampgooch69

This is what kalshi says… If the DEA were to reschedule only certain cannabis derivatives or specific cannabinoids (e.g., move THC or a particular cannabis-derived pharmaceutical to a different schedule) without reclassifying marijuana/cannabis as a whole, that would not qualify as rescheduling marijuana for this contract. Ending the schedule altogether would resolve the market to Yes. Clarification (12/12/25): The Payout Criterion requires that marijuana is legally removed from Schedule I. The mere announcement or publication of a Final Rule in the Federal Register does not satisfy the Payout Criterion if the rule has not taken legal effect. The market resolves based on the actual status of the Schedules under the Controlled Substances Act.

anonymous_otter28

Texas ag opponent wants to legalize THC.

liquidsyphon

THC-A ban is coming up

TroubledAcorn

RYM is not a wild card for long. Schedule 3 can be delayed for who knows how long. But one thing is for certain, either Hemp THC drinks will be banned in December or they won’t. It will be making things alot more clearer for the future or RYM

AverageNo130

Rep. Morgan Griffith (R-VA) is raising the possibility that provisions to reverse the planned federal recriminalization of hemp THC products could be included in a broader budget reconciliation bill during the lame-duck session of Congress. Earlier this year, Griffith and Rep. Marc Veasey (D-TX) filed the [Hemp Enforcement, Modernization, and Protection (HEMP) Act](https://www.marijuanamoment.net/new-bipartisan-congressional-bill-would-regulate-hemp-products-in-contrast-to-ban-trump-signed/), which would keep hemp products legal and enact new regulations on the market...MM

Sawyerthesadist

Actually interestingly enough, one thing that does protect against the negatives of alcohol is good ol THC

MidThoughts-5

T definitely losing the THC vote with his inaction on cannabis rescheduling and hemp thc extension.

GeoLogic23

I think the most important thing to consider is that hemp has completely different potential for profits than other biofuels. No other biofuel feedstock also produces inputs for a market that has the growth and margin potential of the CBD/THC market. If you're growing crops purely for biofuel it's never really been worth it without subsidies. But if you can sell your crops to both the biofuel market and the CBD/THC market, you have a unique business that compliments the country's shift to green energy as well as the shift away from alcohol. The profits don't have to come from actual fuel necessarily either. All these companies involved with biofuel are focused on the tax incentives and stuff like that. In theory hemp should be a big crop in the carbon credits market, since just growing it sucks a lot of carbon.

GeoLogic23

Fear of no interstate commerce happening for medical. They have limited upside as long as they are competely restricted to California. They would also be wanting to participate in the inputs for CPG products containing CBD/THC, as they can grow consistent product at scale cheaper than almost anyone. Not just hemp flower, but consistent product for extraction for major CPG companies that can't risk variation in their product. So if they hemp ban happens later this year, they won't be able to sell to CPG companies in the near future either. Further restricting them to only California cannabis. Also if the hemp ban goes through it'd probably put a damper on other industries that can boost large scale hemp/cannabis growers. Glass House grows a crazy amount of biomass. If hemp is legitimized there will be more ways to profit off "waste" like this for stuff like biofuel. Alcohol companies already upcycle their used hops. Same principle for hemp. But the current ban could screw up even industrial hemp. I'm not worried about Glass House like going out of business or something crazy like that. Worst case in my mind is that Vireo buys them, since they are already partnered and Vireo is buying everyone lol

Mattagascar

Company formed last month, no COA results online, $4+/drink for 1mg THC seltzers. HempMoment strikes again

AverageNo130

Herb Light’s “Cheers Against Prohibition” campaign, launching on Wednesday. Customers who buy a 12-pack of THC drinks can add a six-pack for their congressional lawmakers. The company says it will handle delivery to lawmakers and will include a letter urging hemp support...MM

FatherJackal

Brah this Chinese grown intoxicating synthetic THC analog hemp needs to die already

rockum

That's sad. Think of all those billions consumers won't have anymore because they're now paying more for their THC microdoses. That's less money for Cracker Barrel and grand kids.

1_FCKTRD

The Snowbirds are coming back to Florida for the winter: 10/09/26 - TRLV Medical Marijuana (mg THC) 117,727,743 Marijuana in a Form for Smoking (oz) - 52,924.336

M_from_Vegas

Well take my username as further anecdotal evidence Dunkin Donuts and Dutch Bros (BROS) have taken over as the go to chain over Starbucks in Vegas I don't know if say Toledo Ohio or Peoria Illionis or South Bend Indiana will have local Turkish Coffee or shops with THC treats But I would bet that Starbucks in these places are still losing compared to other chains or whatever local/craft coffee shop is near them... and Dunkin or Dutch Bros will set up shop soon enough to take over Honestly I only see Starbucks when I'm shopping at Mariano's and even then people are just drinking the free samples... same as the Liquor department lmao Again totally anecdotal

M_from_Vegas

I feel like this is wrong Maybe anecdotal, but I currently live in Chicago in one of the popular neighborhoods When I moved in 3 years ago, there were 3 Starbucks within a mile of my apartment All 3 have since closed and been replaced by local shops... I assume similar stories in other neighborhoods The most popular is the one that serves Turkish Coffee, but the place that serves bagels, and the place that serves THC infused treats are also always busy Again maybe anecdotal but Starbucks juat can't seem to compete in my neighborhood

Sawyerthesadist

lol where you getting that? THC drinks I’ve seen are mostly pretty weak

SubtractOneMore

CBD counteracts THC and brings you down What happens is you waste some weed

GuyOnTheCouch420

don't forget showing huge inorganic growth, picking a pie in the sky number like $4B in revenue that they will hit, talking about balance sheet strength and not mentioning dilution, and then some fun macro comments like THC beverages in the US despite them not selling THC beverages in the US lol

SwordfishOk504

Where in those "hemp products" are just THC flower.

GeoLogic23

Couple new companies lobbying about cannabis/hemp. [Heaven Hill Distilleries](https://lda.gov/filings/public/filing/7aeb4410-8abb-4d5a-b2fa-a723801a98d6/print/) is a major alcohol supplier based in Kentucky. [Per wikipedia](https://en.wikipedia.org/wiki/Heaven_Hill): >It is the seventh-largest alcoholic beverage supplier in the United States, the **second-largest holder of bourbon whiskey inventory in the world**, and the largest independent family-owned and operated producer and marketer of distilled spirits in the United States. Heaven Hill is lobbying for "Regulation of spirits, hemp and thc beverages. Tariffs Taxes generally". Their lobbyist only lobbies for one other client, Serralles Distilleries, who are explicitly lobbying against THC beverages. >Seeking closure of 2018 Farm bill loophole that allows the sale of THC beverages. So Heaven Hill is likely on that side of the topic as well. Pretty sure bourbon companies are ones pushing back, which also explains Mitch McConnell's stance earlier. [Nabis](https://lda.gov/filings/public/filing/6341c68d-9d0c-4a6c-91f2-3f73318e97b2/print/) is the other company filing a new registration for cannabis/hemp. They are lobbying with a new cannabis lobbying firm that only works for Nabis at the moment. They are lobbying for: >cannabis, hemp, banking, SAFE Banking Act, appropriations Nabis is a cannabis/hemp wholesale distribution platform. Investors in Nabis include NFL legend Joe Montana, a Doordash co-founder, Y Combinator, and **Artemis Growth Partners**. Artemis Growth have tons of cannabis investments, but they are close with Boris Jordan, as they are co-investors in Bloomwell (Boris' other European cannabis company). Artemis Growth are also close with the Bacardi family, as [Artemis Growth merged with Tenacious Labs](https://www.tenacious-labs.com/news/artemis-growth-partners-and-tenacious-labs-unite-to-create-europes-largest-cannabis-investment-platform) a couple years ago. Tenacious Labs is run by a Bacardi family member, and they rolled up a bunch of CBD companies in recent years. >Mr Clarke, member of the Bacardi family....made a ‘significant minority investment’ in Artemis Growth as part of the broader deal.

LouSwimminn

Market is a scam. Going long $VoodooRangers and $THC

Pereise1

1:1 CBD/THC before sleep still hits for me. Sucks that I can't use it when I'm back in my home country or in my wife's home country in South America.

AverageNo130

New South Wales has officially enacted a major overhaul of its drug-driving laws, creating a new system that will protect registered medical cannabis patients from automatic penalties solely because THC is detected in their system. The Road Transport Legislation Amendment (Medical Cannabis and Driving Offences) Act 2026 received assent from the governor on September 23 and was published in the New South Wales Government Gazette on September 25 as Act No. 33 of 2026. MH

Fun-Photograph3526

I believe a Canadian company created a THC breathalyzer like 2 years ago.. not sure how viable it is or how it’s going these days though

Lanky-Preparation771

Hemp derived THC products are set to be banned in November because Mitch McConnell put that legislatioin in the last shutdown budget bill, which would nullify the loophole from the 2018 farm bill that allowed them.

Calm_Evening_4534

I know a short cut. 1. Take 30mg of THC at about 9:00 EST 2. Make a trade at market open 3. Read news and watch YouTube stories until it hits. 4. Make a few more trades 5. Get something to eat 6. More news and trades There you go I have balanced irrationality with rationality. Can’t go tits up.

Tiddlychinks

It’s not going to happen until someone invents a breathalyzer for THC, which I don’t think is on the horizon.

Rybn47

I got a position in Tenet healthcare corp (THC) because its a cool name and cooler ticker, got a +25% I also read a regard talking about fedex going up some years ago and bough and got a +10% in a day

Fun-Choices

When I got fired in February, I somehow thought rewarding myself with a pound of weed would be a good idea. I actually kind of saw it as an investment because I smoked so much anyway. I thought a pound would last me two years. I finished it August 25 so I am almost a month sober from THC. I wanna quit the alcohol so goddamn bad.

AverageNo130

A newly published[ study](https://academic.oup.com/jat/advance-article-abstract/doi/10.1093/jat/bkag084/8817543) finds that the amount of cellular material collected in an oral-fluid sample can substantially affect measured THC concentrations, identifying another source of variability in saliva-based marijuana testing. MH

CornMonkey-Original

it’s often best to just feed the insomnia THC. . .

MidnighT0k3r

I'm not suggesting you take it so much as you read about it. There are studies being done and I for example am very eager for when cannabis based medicine is more of a thing.  Not just for stuff that I discussed above but sooo much more.  For example, there's another type of cannabis that also not rich in thc and it's chemotype 4 which is rich in cbga. It helps me with reducing my migraine frequency, lowers my inflammation and chronic pain, reduces my ibs-c symptoms, reduces my neuropathy from stenosis and spinal injury. I can't get medicine for some of these things outside of cannabis.  So... what I'm getting at is I'm just trying to share inflammation that cannabis isn't just all about getting high off thc. The plant actually offers significantly more medicinal benefits with the other cannabinoids and chemotypes. It is however mostly fair to assume when you smell cannabis it is 95% of the time chemotype 1 cannabis which is rich in THC and intoxicating because of it.  If however you really did want to look deeper into it and consider trying cbd (id recommend talking to a doctor or pharmacist first to make sure cbd doesn't interact with anything you may already be taking).... You should know there are different types of cbd products. Ones made with isolate have no detectable levels of thc. This doesn't mean no thc, it means of it is there it's below the levels we can measure. So like below 0.001% or something like that.  Ones made from anything else like full or broad spectrum extracts will contain small levels of thc that you may want to avoid.  Also with edibles not everyone processes it the same so what 5mg feels like for one person can be different to another.

ValuableHippo3931

whats the ticker for THC drinks

skyplt29

I agree Geo. I get these 8-K reports directly from Tilray Investor Relations so knew this was a debt for equity swap. This is not as bad as other dilutions but I would like to see them able to start paying down debt from operating profits, not issuing more shares. I am not sophisticated enough to see the relationship between shorting a stock, then swapping equity to cover when the stock price gets driven down. But one has to wonder how the stock could get driven down from 4.50USD to 4USD (10%) on no news. Perhaps this has something to do with that plummet. I sincerely hope Tilray's C-suite is executing a well thought out strategic plan to increase efficiencies in the brands they have acquired, pay off debt, and move forward with synergies (perhaps even using their alcohol distribution network to move CBD and THC based drinks). But I am growing tired of the constant dilution, especially when Simon/Merton state on Q calls that this phase of the company's growth is over. So yes, this was not a terrible filing, but shareholders are paying for this when it is time for operating profits to pay off debt.

Apple2o

A lot of you have never had a blunt laced with THC diamonds and it shows

CornMonkey-Original

well on my way to 120mg of THC today - we are not the same. . .

grimeyGR1

They don't have winning brands. They sell blended 2x1g joints of floor sweepings and lab inflated THC boof

Creepy_Translator_69

Trying to stay up for the ADBE earnings call THC got other ideas

Strong-Comment-7279

These "investments" in general - vaping, tobacco replacement, THC vehicles.

Glittering_Dig3798

When I quit vaping THC I developed chronic diarrhea. Didn't connect the dots for a month or two. One night I realized the correlation, reupped, and have been better since. Just my $0.02

Orennji

What I'm trying to wrap my head around is the fact that their volume of smokable ounces has actually been mostly stable from 2023 to 2026 while their THC milligram's declined. One interpretation I can think of is that their product mix is trending towards low potency medical consumption favored by a mostly older/elderly demographic. Just a guess, though, since I haven't looked at any detailed breakdown based on form factor or strains.

Orennji

Been using LLMs as unpaid interns to sift through OMMU trends, with some quick manual skimming to double check. Pretty interesting trends here for THC mg's per storefront, once you zoom way out and look at the entire market: > THC volume per store: 2023 → 2026 Operator 2023/store 2026/store Change Trulieve 1.01M 647k −36% MÜV / Verano 415k 602k +45% Curaleaf 667k 633k −5% AYR  781k 603k −23% Surterra 658k 275k −58% FLUENT 393k 629k +60% Sunnyside / Cresco 197k 399k +103% GTI / RISE 233k 921k +296% Cookies 267k 465k +74% Jungle Boys 252k 644k +156% Sunburn 553k 889k +61% GrowHealthy 315k 520k +65% Sanctuary 231k 346k +50% Insa 162k 480k +197% The Flowery 926k 521k −44% The big story isn't simply that the independents are growing. A number of the smaller/premium operators have dramatically improved their stores' throughput. The standout is GTI: 233k → 921k THC mg/store/week That's almost a 4× increase while going from 9 to 24 stores. Jungle Boys is also striking: 252k → 644k, +156% And Sunburn: 553k → 889k, +61% Meanwhile, Trulieve went from an extraordinary 1.01M/store to 647k, despite growing from 127 to 170 stores.  One thing I find particularly interesting The ranking has changed substantially: 2023: Trulieve — 1.01M Flowery — 926k AYR — 781k Curaleaf — 667k Surterra — 658k Sunburn — 553k MÜV — 415k FLUENT — 393k GrowHealthy — 315k Cookies — 267k Jungle Boys — 252k 2026: GTI — 921k Sunburn — 889k Jungle Boys — 644k Curaleaf — 633k FLUENT — 629k AYR — 603k MÜV — 602k Trulieve — 647k (actually #3 if sorted strictly; the close grouping makes the ranking easy to misread) GrowHealthy — 520k Flowery — 521k Insa — 480k Cookies — 465k The important takeaway is that the best independents aren't merely surviving against the MSOs—they've become much more productive per location. And this makes Sunburn particularly interesting: at 889k mg/store, it's now producing about 37% more THC volume per store than Trulieve, despite Trulieve's enormous scale.

trent_upscale

Laying in bed rn, mind numbed by THC. What do you want from me

fuentescoffee

Worth flagging for anyone reading this as one more store on the pile: Georgia stopped being the market most people still have in their heads about ten weeks ago. SB 220 took effect July 1. The 5% THC cap is gone, replaced by a 12,000mg cumulative possession ceiling, and flower and vaporizers are on the menu for patients 21+ — smoking botanical cannabis is still not permitted, so inhalation is vape-only. Qualifying conditions widened at the same time: lupus, HIV and IBD added, and the "end-stage" limiter stripped from cancer, MS and Parkinson's. That last one is the change most likely to actually move the registry. So a Georgia store opened this month isn't comparable to one opened last year — different basket, different eligible pool. The number I'd want here is same-store growth at the existing Georgia locations since July 1, not the footprint count. One thing that cuts against footprint framing generally: post-rescheduling, licensed independent pharmacies with DEA registration can dispense in Georgia, and Trulieve said on July 1 it was already supplying a dozen-plus. If that channel scales, owned stores stop being a clean proxy for Georgia share.

mfairview

as is always, cost will be passed onto the consumer and only the most efficient or notable companies will prevail. the one notable thing I would say about THC products is that it can exist in many form factors, from inhalents to drinks to foods. that gives it a massive surface to operate in.

AverageNo130

A handful of congressional Republicans threatened this week to upend their leadership’s agenda in protest of legislation to [delay the scheduled federal recriminalization of hemp THC products](https://www.marijuanamoment.net/house-passes-bill-to-delay-hemp-thc-product-ban-sending-it-to-trumps-desk/) from taking effect. Two Democrats—Reps. Marie Gluesenkamp Perez (D-WA) and Jared Golden (D-ME)—voted with Republicans to approve the rule, 210-208. MM

AverageNo130

>U.S. House Passes Spending Bill Delaying Federal Hemp THC Ban, Sending It to President Trump. MH

skyplt29

Rep. [Chip Roy](https://www.cnbc.com/video/2025/08/28/rep-chip-roy-on-congressional-stock-trading-ban-u-s-governments-stake-in-intel.html), R-Texas, sent a letter on Monday to House Appropriations Committee Chair [Tom Cole](https://www.cnbc.com/tom-cole/), R-Okla., and House Budget Committee Chair [Jodey Arrington](https://www.cnbc.com/video/2026/07/30/this-is-emergency-funding-says-house-budget-chair-on-reconciliation-3-point-0.html), R-Texas, outlining his concerns with the stopgap spending measure, among them its funding for Planned Parenthood and the absence of a ban on hemp products that contain THC, the psychoactive chemical in marijuana. “I have serious concerns about simply extending the status quo. Members should be clear about what passage of this legislation would mean: Congress would once again affirmatively fund policies we have spent months fighting to change,” Roy wrote. And Rep. Andy Harris, R-Md., who chairs the Freedom Caucus, [told Punchbowl News](https://x.com/JakeSherman/status/2094533287830245683?s=20) he would vote to block the rest of the GOP’s agenda for the week over his objection to the spending measure. But their opposition was not enough to complicate the vote. With Democratic support, Johnson was able to pass the funding measure even with some GOP defections.

AverageNo130

Endovia Health Sciences says it plans to make its next Food and Drug Administration (FDA) submission for CannEpil in the coming week and request a meeting with the agency to discuss the cannabinoid drug’s regulatory and development pathway. CannEpil is a pharmaceutical-grade oral formulation made with isolated cannabidiol (CBD) and tetrahydrocannabinol (THC). The drug was originally developed for drug-resistant epilepsy, and Endovia holds exclusive worldwide rights to develop and commercialize it for human and veterinary uses. MH **Endovia Health Sciences:** In August 2026, Splash Beverage Group completed a corporate transformation and rebranded into [Endovia Health Sciences](https://www.sec.gov/Archives/edgar/data/1553788/000173112226001047/e7845_ex99-1.htm) (trading on the NYSE American under the ticker symbol **EDVA**

AverageNo130

The U.S. House of Representatives is expected to consider a bill this week that contains provisions to [delay the federal recriminalization of hemp THC products](https://www.marijuanamoment.net/senate-rejects-amendment-to-keep-hemp-thc-product-ban-on-track-for-november-teeing-up-delay-trump-pushed-for/) that is currently scheduled to take effect in November. The legislation has already been approved by the Senate. MM

AverageNo130

A low-THC, full-spectrum cannabis extract significantly improved core and associated symptoms of autism spectrum disorder in children and adolescents compared with placebo, according to a Phase II/III [randomized clinical trial](https://www.neurotherapeuticsjournal.org/article/S1878-7479%2826%2900203-5/fulltext). The study examined children with moderate-to-severe autism spectrum disorder (ASD). MH I guess this is bullish for CWBHF and their own autism drug in phase 2 trial.

Hwangoutpltr

If your reading this and you're high on THC, you left your car interior light on

answerguru

You can buy THC powder to just make your own. In bulk around 1000mg for $120-150.

danaknyc

Only issue with THC drinks is that they’re $5/can. Also, the state by state limits are idiotic. NY is great with the 10mg cans, but go to New Orleans or Mass and you’re capped at 5mg. Looking forward to the day where I can pick up a six pack for $15 and be on with life.

GeoLogic23

Hill Street (now Hill Incorporated) went [bankrupt last year](https://www.thenewswire.com/press-releases/1ArbF4mvN-hill-incorporated-makes-assignment-in-bankruptcy-under-the-bankruptcy-and-insolvency-act-canada.html), so idk if Lexaria has regained those rights or not. >**November 21, 2025.**... Hill Incorporated....announces today that it has made an assignment in bankruptcy pursuant to the *Bankruptcy and Insolvency Act*. >Due to dramatic price compression, difficulty in collections of accounts receivable, and other significant challenges in the cannabis industry affecting the Company’s DehydraTECH licensing business, along with the significant cash outlays and costs... I just know Lexaria specfiically said they had "renewed corporate interest" from both CBD and nicotine sectors. So yea, my initial though was something regarding Cannadips. I initially found Lexaria's comment about renewed interest from the CBD sector after Tilray released their pouch product. That made me go look at Lexaria again, as they are the main connection I know to CBD/THC pouch products. And pouches are like the key product for big tobacco maintaining their sales right now. Cannadips also had an ex-Altria guy running them for a while, and Cannadips are an investment by Poseidon Asset Management. Besides being longtime cannabis investors, Poseidon has also invested in hemp beverages (RYM), and they were early investors in JUUL. So they already have experience selling companies to Altria.

Kbarbs4421

After digging into this one a bit.... Lexaria developed bioabsorption technology that significantly improves absorption of cannabinoids, nicotine, and likely other molecules. Altria took a stake in the company (16.67%..?) and also acquired the rights to use the tech for oral nicotine products, in exchange for royalty payments. There is no cannabinoid based relationship between the companies...though there obviously could be if fed law/reg changes. Altria has the option to outright acquire the company, which would bring their patents under Altria ownership. It would also eliminate the oral nicotine royalty payments. Rights to use the tech for cannabis products has been a) outright sold to Hill Street BevCo for consumer recreational products (which has been sublicensed to others, including Lume, Cannadips, etc?), and b) long term licensed (through 2030? 2035?) for sub-0.3% THC formats to Cannadips. Meaning Lexaria no longer owns the rec rights and does not control the cannabinoid/wellness rights. The only thing they're left with is the theoretical FDA approved pharma line, right? Initially, this intrigued me from a cannabis perspective. If anything, it seems more like a nicotine play with a pharma kicker for Altria. Perhaps I'm misreading it. Does make me wonder if there's a relationship in the works between Altria/Cronos and Hill Street. Or Lume. Or Cannadips.

SwordfishOk504

Possession of any amount of recreational cannabis is an imprisonable offence in Texas. And yet in many places where Texans buy beer, they can also find drinks infused with tetrahydrocannabinol (THC), the psychoactive component of cannabis. THC drinks are flying off the shelves—and not just in the Lone Star State. Their rise stems from changing social mores and regulatory confusion. Start with the first. Alcohol sales are declining as youngsters drink less than older generations. But some teetotallers welcome a buzz. THC was once stigmatised for leaving users sprawled and giggling on the sofa, wrist-deep in a bag of crisps. Today, though, it has a veneer of “wellness”. Many THC drinks have few or no calories; some include ostensibly healthy extras such as plant extracts. Makers boast that they do not cause hangovers. Some restaurants have even started to offer them, noticing a rise in “cocktail culture”. thc drinks come in a variety of strengths, so pay careful attention to the dosage: consuming 25mg rather than 2.5mg can lead to several deeply unpleasant hours. According to the Hemp Beverage Alliance, a trade group, in 2025 the number of distribution points more than doubled (from 133,500 to 306,000), as did the sales by volume (from about 700,000 case equivalents to 1.6m), from a year earlier. The Brightfield Group, a cannabis consultancy, predicts that revenue from THC drinks could exceed $4.4bn by the end of the decade, up from less than $200m in 2020. Total Wine, America’s biggest wine retailer, sells them in 22 states (there are 24 where cannabis is illegal). Their rise is owed partly to the morass of legislation governing American agriculture, known as the farm bill. Its most recent version lets farmers grow hemp with a THC content of no more than 0.3% by dry weight; anything stronger is classified as marijuana and remains illegal under federal law. But manufacturers can extract THC from large quantities of legal hemp and use it to make drinks containing intoxicating doses. Anti-cannabis lawmakers have noticed: last year Congress passed legislation that would limit THC to 0.4mg per container, in effect killing the hemp-drinks sector. But the Senate recently voted to briefly postpone the crackdown, and on August 10th a bipartisan bill was introduced that would exempt THC drinks from the restrictions and regulate them like alcohol. Its sponsors do not want to kill a golden, if slightly stoned, goose. This would open the federal government to charges of hypocrisy for approving one form of hemp while outlawing another. But it would also boost businesses and protect a steady stream of tax revenue. The industry is already high. Whether it becomes mighty—or goes up in smoke—will depend on lawmakers. ■

ValuableHippo3931

THC drinks are the next thing so whats the ticker

mfairview

AI Research 1. Final Adult-Use Rescheduling OrderExpected Outcome: Following the public release of the 2,533-page DEA transcript on August 25, 2026, Chief ALJ Derek Julius is highly expected to formally recommend shifting adult-use cannabis to Schedule III. DEA Administrator Terry Cole will then issue the final agency rule. This will effectively eliminate the 280E tax penalty for recreational multi-state operators (MSOs), mimicking the tax relief given to state-licensed medical operators.When to Expect It: Q4 2026 (October – November). Following the closing briefs from designated hearing participants, the administrative transition is expected to conclude before the winter recess. 2. SAFE Banking Act of 2026 (H.R. 9471) Committee VotesExpected Outcome: The bill faces a deeply divided Congress. However, because President Trump explicitly issued an Executive Order backing federal cannabis reclassification, the bill has a high probability of passing out of the House Financial Services and Judiciary Committees. It is expected to clear the House floor but face heavy structural gridlock in the Senate.When to Expect It: November – December 2026. Expect legislative momentum to peak during the post-election "lame duck" congressional session. 3. Decisions on MSO RICO Class-Action DismissalsExpected Outcome: Federal judges in Illinois and Connecticut are reviewing motions to dismiss Murray v. Cresco Labs and Duke v. Curaleaf. The court is expected to deny the MSOs' motions to dismiss. This will force the cases into discovery over whether MSOs illegally marketed recreational items as having clinical, unapproved medical benefits. Concurrently, Palomar Insurance' parallel lawsuits to completely deny policy coverage for these operators will likely proceed, creating a severe capital strain on corporate legal defense budgets.When to Expect It: Q1 2027 (January – March). Federal docket timelines for complex multi-party RICO actions typically rule on initial motions to dismiss within 6 to 9 months of their initial mid-2026 filing dates. 4. 2018 Farm Bill Hemp Loophole ClosureExpected Outcome: The enforcement date to officially close the structural loophole on unregulated hemp-derived cannabinoids will take effect. This is expected to instantly wipe out nearly 95% of existing synthetically derived or high-THC hemp products from gas stations and bodegas nationwide, consolidating the consumer market directly back into heavily regulated, state-licensed dispensaries.When to Expect It: November 12, 2026 (Locked-in regulatory effective date).

babaganoush-ish

From chatgpt: **My hypothetical Julius ruling** If I actually had to write the bottom line after this record, mine would probably look approximately like this: **FINDINGS** The record establishes that marijuana presents meaningful risks of abuse and adverse health consequences. The evidence further demonstrates substantial variation among marijuana products with respect to potency, formulation, route of administration and dosage. The opponents have presented credible evidence concerning cannabis-use disorder, psychiatric effects, impaired driving, high-potency products and limitations in portions of the medical literature. However, the evidence does not establish that marijuana lacks a currently accepted medical use. HHS’s scientific and medical evaluation concluded otherwise, and the Government presented evidence supporting that determination. The opposing parties identified limitations in that analysis but did not sufficiently undermine its central conclusion. Moreover, evidence concerning the risks associated with marijuana does not, without more, establish that Schedule I remains the appropriate classification. **CONCLUSION** After consideration of the administrative record and the applicable statutory factors, I would recommend that the marijuana presently subject to this proceeding be **transferred from Schedule I to Schedule III of the Controlled Substances Act**, subject to the regulatory controls applicable under federal law. **But I would attach significant caveats** This is where I think Julius could surprise cannabis investors. A **Schedule III recommendation doesn’t require him to endorse the cannabis industry**. He could write a fairly harsh 100+ page decision cataloguing high-potency THC, psychiatric risks, impaired driving, dependence, questionable medical claims and deficiencies in state regulatory systems… …and still conclude: **Schedule III.** Those two things aren’t contradictory. In fact, after reviewing the testimony, I think that’s one of the more plausible outcomes: **a reluctant, tightly reasoned Schedule III recommendation with extensive findings about marijuana’s risks.** **What could change my 70–80% assessment?** The **post-hearing briefs**. That’s important because Julius’s preliminary order specifically said there would be no oral closing arguments; instead, parties would submit post-hearing briefs under 21 CFR §1316.64. And right now DEA’s public 2026 NPRM page lists all 11 transcripts plus the transcript/post-hearing briefing order, but **does not presently list the parties’ post-hearing briefs themselves**. Those briefs matter because a witness can give persuasive scientific testimony but still lose on the **law**. The briefs are where each side connects the testimony to the CSA and explains why Julius legally can—or cannot—reach Schedule III. So I wouldn’t move my probability substantially higher than \~80% until seeing those arguments. **One more important point** Even if my hypothetical Julius issues: **RECOMMENDATION: Schedule III** that **doesn’t itself reschedule marijuana**. Julius is the ALJ developing the administrative record and recommended findings. The ultimate agency rulemaking still has subsequent steps. DEA describes the process as formal rulemaking involving administrative review after the evidentiary proceeding.

babaganoush-ish

From chatgpt: **My hypothetical Julius ruling** If I actually had to write the bottom line after this record, mine would probably look approximately like this: **FINDINGS** The record establishes that marijuana presents meaningful risks of abuse and adverse health consequences. The evidence further demonstrates substantial variation among marijuana products with respect to potency, formulation, route of administration and dosage. The opponents have presented credible evidence concerning cannabis-use disorder, psychiatric effects, impaired driving, high-potency products and limitations in portions of the medical literature. However, the evidence does not establish that marijuana lacks a currently accepted medical use. HHS’s scientific and medical evaluation concluded otherwise, and the Government presented evidence supporting that determination. The opposing parties identified limitations in that analysis but did not sufficiently undermine its central conclusion. Moreover, evidence concerning the risks associated with marijuana does not, without more, establish that Schedule I remains the appropriate classification. **CONCLUSION** After consideration of the administrative record and the applicable statutory factors, I would recommend that the marijuana presently subject to this proceeding be **transferred from Schedule I to Schedule III of the Controlled Substances Act**, subject to the regulatory controls applicable under federal law. **But I would attach significant caveats** This is where I think Julius could surprise cannabis investors. A **Schedule III recommendation doesn’t require him to endorse the cannabis industry**. He could write a fairly harsh 100+ page decision cataloguing high-potency THC, psychiatric risks, impaired driving, dependence, questionable medical claims and deficiencies in state regulatory systems… …and still conclude: **Schedule III.** Those two things aren’t contradictory. In fact, after reviewing the testimony, I think that’s one of the more plausible outcomes: **a reluctant, tightly reasoned Schedule III recommendation with extensive findings about marijuana’s risks.** **What could change my 70–80% assessment?** The **post-hearing briefs**. That’s important because Julius’s preliminary order specifically said there would be no oral closing arguments; instead, parties would submit post-hearing briefs under 21 CFR §1316.64. And right now DEA’s public 2026 NPRM page lists all 11 transcripts plus the transcript/post-hearing briefing order, but **does not presently list the parties’ post-hearing briefs themselves**. Those briefs matter because a witness can give persuasive scientific testimony but still lose on the **law**. The briefs are where each side connects the testimony to the CSA and explains why Julius legally can—or cannot—reach Schedule III. So I wouldn’t move my probability substantially higher than \~80% until seeing those arguments. **One more important point** Even if my hypothetical Julius issues: **RECOMMENDATION: Schedule III** that **doesn’t itself reschedule marijuana**. Julius is the ALJ developing the administrative record and recommended findings. The ultimate agency rulemaking still has subsequent steps. DEA describes the process as formal rulemaking involving administrative review after the evidentiary proceeding.

No_Presentation9490

You could also have just bought Altria who is getting into THC and has massive market penetration already and be paid 6% in yearly dividends just to hold the position

aznexile602

This comment made me laugh. But I am also pretty high right now. Both on the THC and the ETH.

SwordfishOk504

No, loophole that has allowed THC products being sold under the guide of "Hemp" is rightfully being closed.

it_wasntt_me

It’s like a THC tickle more than a high

Altair82

Look into hippocampus and tips for improving its health (hint: lots of cardio, sleep, and nutrition) Look into Delta 8 to replace THC. It doesn't flood your brain with as much dopamine Look into shrooms microdosing for plasticity and also Lion's Mane for neural production Short answer: yes. You can claim back your memory. I did it and I'm sure you can also. I started smoking at 15 also.

skyplt29

Really very good advice, and timely. Though I know all of these things, greed has a way of clouding my judgement. Yep...weedstocks has crept up to 25% of my portfolio. That's not good. I got sucked in last December on the S3 Executive Order. I did not sell that news event! The upshot is the shares are held in tax free accounts, so if they explode it is a home run. The bad news is this means I cannot write off the losses either, which continue to fester this year. Risk/reward? That's where the major rethink is happening. I know weedstocks are high risk. Unfortunately, I am beginning to think the reward is just not there to justify that risk. This primarily has to do with the legal/regulatory hurdles and what we have clearly seen over the last ten years of how low a priority this is for the USA government and how much resistance there is from well funded organizations looking to keep children off drugs and sniffer dogs employed. I still believe medical applications and low dose THC drinks is where the potential lies. I am astounded the vast majority of the population either don't know or don't care (perhaps both) about viable alternatives to destructive drugs (Tylenol, opioids) and alcohol. Wow, just wow. I thought by now the evidence would have convinced politicians...but I think the pharmaceutical and alcohol lobby groups are simply too well established and the misinformation too deep. Wish it was otherwise...but definitely revisiting my risk/reward assessment. Will look to reduce this portion of my portfolio to around 10%.

TCNNF_Moon-_

Trulieve all lined up for next week. I think we may be looking at only S3 medical and not rec. I have a feeling they will stretch us all out a while longer until the real reform that’s needed actually happens Medical should be controlled and rec also, but with different allowed THC levels. Deschedule rec by 2030 maybe. 🤔 With this sector though. No one knows. Well expect for all the people that do know…

Wows_Nightly_News

HTZ the new THC

floatingdownthesound

Really appreciate this, easily the most useful comment I've gotten, and it hits harder coming from someone who maintains the same 50-state column. Shipped most of it: Added the second axis you called out. There's now a "sales live" flag (live / launching / blocked / none) separate from legal status, so Virginia reads legal + launching instead of pretending to be an operating market. And the last-action date per bill is now visible on mobile, since a stale "in committee" with no date is worse than nothing. The per-provision hemp countdown is the one I'm sitting on. You're right that one number flattens a staged calendar, so I'll break out total-THC, the 0.4mg cap, and the manufactured-cannabinoid exclusion into separate dates once the delay actually gets signed. The status field that quietly rots is the exact fight. If you ever want to compare notes on keeping Budpedia current, I'm in. Thanks again.

fuentescoffee

Solid build, and putting "legislative data via LegiScan, CC BY 4.0" on the page already puts you ahead of most trackers in this space. Two bits of honest feedback, from someone who maintains the same 50-state legal-status column on a cannabis directory (disclosure: I run Budpedia — not a bill tracker, but that status field is the part that quietly rots on me): The 24 / 18 / 1 / 7 bucket split will bite you on edge cases. DC is the classic — possession legal, retail sales blocked by the congressional appropriations rider — and it doesn't sit cleanly in any of the four. Same issue with states that legalized but haven't opened stores. A second axis ("legal" vs "sales live") fixes most of it. Second: the single "123 days to Dec 11" hemp countdown flattens what's actually a staged calendar. The CR moved several distinct pieces to that date — total-THC measurement, the 0.4mg/container cap, the manufactured-cannabinoid exclusion — and an operator reading one number plans for one cliff. Per-provision dates would be the highest-value thing you could add. Smaller: surface last-action date per bill. LegiScan's status lags in a few states and a stale "in committee" is worse than showing nothing.

Gambelero

Good point Sky. That “lack of interest” makes me skeptical that people in Congress will put in the hard work necessary to build a regulatory framework that allows non-intoxicating hemp for various uses but closes the high THC loopholes. They never meant to allow the high THC exceptions in the first place. My expectation has always been that they would kick the can down the road with another one year stay on the hemp ban. Fighting over a one month extension would seem to indicate that they seriously want fix things.

AverageNo130

A U.S. Senate dispute over whether to [implement a forthcoming ban on hemp THC products on time as scheduled or instead delay it](https://www.marijuanamoment.net/senate-rejects-amendment-to-keep-hemp-thc-product-ban-on-track-for-november-teeing-up-delay-trump-pushed-for/) in order to give lawmakers more time to craft regulations as an alternative to prohibition has transcended typical partisan and ideological lines. In a vote of 61-32 34 Democrats and one independent who caucuses with Democrats took the pro-hemp position by voting to table the prohibition amendment from  Sen. Ted Budd (R-NC) . MM

Kbarbs4421

> [Trump laid out the argument to Sen. Ted Budd (R-N.C.) for why the White House supports a provision in the stopgap funding bill that would delay the ban by about a month .... The White House is working on a broader framework addressing THC products for medicinal uses, and officials are concerned the ban could complicate those plans. .... White House liaison James Braid .... committed to no further delays — beyond the one included in the short-term funding measure.](https://www.axios.com/2026/08/05/trump-ted-budd-senate-republicans-hemp)

GeoLogic23

It at least pushes it into the lame duck session, where sometimes things actually get done. The last Farm Bill was passed during a lame duck session. Imo they have to do something to make hemp not conflict with Trump's CBD policy, which is up to 3mg THC.

GeoLogic23

>If there was a burning desire for them, people would go get them. First of all, you'd make the worst marketer. Half of building a brand is just getting it in front of your target consumer, not making them come to you. The drinks market does not target people who go to dispensaries. If you're routinely smoking cannabis, drinks are probably not your market. But there is a [clear market](https://www.reddit.com/r/weedstocks/s/G3mi60kURn) for them. And you really need to read more about beverage distribution, and how critical it is to keeping costs down, because drinks are heavy. You simply cannot build a national beverage brand without tons of distribution partners. [See how you still think THC drinks cost $6 each? ](https://www.binnys.com/extras/thc/) You're just choosing to imagine what the beverage market is like based on the past, instead of realizing how it has changed in recent years since retail shifted in the US. Take Celsius for an example of the importance of distribution for beverages. If people wanted to drink Celsius they would have went and got them, right? **But they didn't for years**, until they were in Pepsi's distribution line and suddenly were right in front of people's faces at grocery stores and were the hottest energy drink for a while. I've literally tried Celsius myself, for no other reason than it was there in front of me. I decided they sucked, but I tried them multiple times. >The drinks guys are burning a ton of cash and diluting like crazy in order to bet on a future that may or may not happen. I much prefer the people making money off selling products that are desirable today. Why are you trying to turn this conversation into a Canopy vs Auxly/Cronos debate or something? I told you I've been invested in both Cronos and Auxly for years. I'm trying to explain why they are simply a completely different investment thesis. And again, Canopy has NOT been burning money on drinks infrastructure. **They've been burning money a lot of other ways.** They already have the Constellation infrastructure if they need it. Now Tilray on the other hand has been burning money on drinks infrastructure, because they don't have a Constellation to rely on.

skyplt29

I suspect many of us here could share some eye watering (soul sucking?) stories. Believe it or not I got completely out just before the Nov 2024 election as I suspected Harris would lose. I realized significant losses but spent most of 2025 on the road to financial recovery. I was doing well in other sectors, but by late Nov/early Dec 2025 there was the promise of an Executive Order on S3. Trump was also shouting "Drill baby drill" and oil was around 57USD a barrel, and projected to go lower as production ramped up. Seemed like a no-brainer to sell some underperforming oil stocks and jump back into this sector for the long awaited rescheduling. Biggest mistake of my investment career! Watching these weedstocks move toward ATLs whilst those oil stocks I used to own hit all time highs is excruciating. Who knew the President who had promised not to get into any overseas "forever wars" would put us right into the middle of one with bothering to run it past Congress. Who knew Iran would wake up to their power over the Strait of Hormuz. Wow. Not sure where this is all headed. If Iran (and Oman) begin taxing ships transiting Hormuz I doubt oil will get much lower. Cost of living will continue to skyrocket...and that jobs report on Friday, sobering. But who the fuck knows anymore. On the 17th of Aug we will supposedly getting some news on rec S3, but again, who the fuck cares anymore. I experienced some incredible gains with Canopy when Constellation jumped in with 5B. Rode that from 32CAD to 70CAD. Wish I never experienced that high. I then got hung out to dry when I was over leveraged on margin when Hindenburg broke the story on Aphria. Seen it all...fake walls, carmalized lungs, THC absorbed by aluminum cans, threat of being arrested if it was found out you were invested in weedstocks, and the kicker, the S3 Executive Order being a "sell the news event" 45 minutes before the actual signing. Ironically, the Situational Awareness hedge fund implosion and Leopold Aschenbrenner's massive losses (due to being overextended on AI investments) brought back harsh memories of my margin buys on Aphria. I lost over 200K on that (had to sell other investments to cover). Ever since I have been trying to make that back...I haven't. On the bright side, I have never bought on margin again. It's one of the reasons I am reluctant to get into Puts and Calls. Whereas I used to write off the negative comments of the FoodCooker types, the sad part is they are being supported by the share price action. Too early? Too dumb? Too egotistical to admit I made a huge error? Likely a combination of all of that. But I remain here because of my personal experience with CBD and it making life so much better in terms of arthritis pain management. Why they still sell Tylenol is beyond me. I won't go near that liver stretching drug. Now a low calorie THC drink that provides a measure of 'taking the edge off' but one would need to drink several gallons to get stoned is a good thing I believe. Perhaps one day people will be order a THC drink and not feel as though they are a drug addict. Sad that alcohol is not considered in the same light. Hard to know what is behind a one month extension on the hemp laws...it does not seem worthwhile. The astounding thing about all of this is I actually still believe there is going to be a breakthrough here. As you say, it also means I was wrong. I was definitely wrong.

skyplt29

Another week in weedstocks has come and gone. A long winded summary: Mixed feelings... Though not a fan of the present government of my country, I am relieved to see Todd Blanche get the vote. As far as DOJ's go, Blanche is about the closest this sector has come to having someone in that position who is at least somewhat understanding of the situation. We'll see. I am hopeful of something on 17 August, but anyone who has been invested in this sector for more than a minute knows it is really hard to tell what is good for this sector. It's been mostly bad. Then there was earnings week. None of the reports were surprisingly good, or spectacularly bad. Meh. It seems we have hit the doldrums of companies treading water and hoping to survive until there is reform. It has been far too long coming. I really don't expect much more on the 17th other than a report that the hearings were completed, objections were considered, and they will move forward with the 'process' of rescheduling. How long this 'process' will be is the key. Maybe a timeline will emerge. Is this a big enough issue to get resolved just before the mid-terms and hopefully sway a few on the fence voters? Not sure. I don't think this sector is really on anyone's radar; particularly sobering was yesterday's volume. Even those MSOs and LPs that reported earnings did not even trade their normal daily volume. I take this as a sign that nobody is interested. It comes down to S3, 280e, SAFER, and uplisting. Trulieve demonstrated that uplisting without rescheduling is not the answer. I expect most institutional investors will stay away (for legal reasons) until rescheduling allows them to invest. Uplisting alone will not attract institutions. It will have to be reschedule, 280e clarification, then institutions. I also believe the average retail investor has seen enough carnage here to support the idea of waiting until there is a definitive change in the wind. Will that change be signalled on 17 Aug? I am not holding my breath. The only aspect left is the "surprise" factor. Maybe something will come out of left field. Who knows. On a personal note, weedstocks has completely changed my approach to risk. I am now a 'scared' investor in other sectors which makes me somewhat weaker. For example, with all of the negative press about SpaceX, I came close to buying when it was hovering around 100USD as this was about 40% off of its IPO price. For those who might recall Facebook, it had a similar trajectory before taking off. When I saw SPCX at 105 I was tempted to buy, but then my "weedstocks thinking" kicked in which is basically "it will go lower". Yesterday I watched companies in this sector do "okay" on low volume post earnings while SPCX jumped 15% on twice the average volume. Foodcooker makes much about meme stocks, yet here is a company that is nowhere close to a profit about to unlock 20% more shares and it goes up 15%. Sounds like a weedstock around 2021! I remain invested in this sector for two primary reasons. The first is my belief in the medical aspects of CBD. It has been a game changer for me in terms of easing arthritis pain. I have not taken a Tylenol in over five years. CBD (used to use oil, now gummies) takes the pain away and I get a much better night's sleep. Low does THC drinks now have my attention. I am not out to get 'stoned' or too high when socializing. I do enjoy having a few drinks in a social setting and like how a bit of alcohol functions as a mood enhancer. The idea of achieving this with a low calorie alternative that won't harm my liver is enticing. The lobbyists and gatekeepers in government make a lot of noise about marijuana being a 'gateway drug'. This is where I think this sector could do better. The best news I have heard in awhile is the move toward low dose THC drinks. Right now less is more in the alcohol industry. I am seeing ads for Arkay vodka as a "zero calorie zero alcohol" alternative. The ad shows a bunch of young people just coming off of their workout and gathering around for a shot of Arkay vodka. This demographic appears to be willing to pay more for less. Something weedstocks could learn from. Low dose, no calorie, non-gateway. CBD and THC should be marketed as 'safe' alternatives. Really, that is what they are (at least for me). It's been the alcohol and pharmaceutical lobbying groups (who give politicians lots of money for re-election) that control the narrative on this sector.

GeoLogic23

Here's just some links. Listen to practically anybody in the hemp beverage and/or alcohol space talk about these products. You'll understand the shift that has been happening over the last several years. [Minnesota liquor store example](https://www.digitsagency.com/digits-from-na-to-thc-retail-media/) >The U.S. cannabis market is projected to reach $123.6 billion by 2025, with direct retail sales exceeding $35 billion. Within this massive market, beverages represent the fastest-growing format >**At Top 10 Liquor, THC drinks already account for 10% of total sales** and are expected to double by 2026. >Total Wine and regional liquor chains have gone further, replacing 10-20 feet of craft beer sets with THC products. [Minnesota overnight success JUST by switching retail.](https://hightimes.com/business/move-over-booze-weed-drinks-pulled-1-1-billion-in-u-s-sales-in-2024/) >The shift was sparked by the 2018 Farm Bill, which decoupled hemp from marijuana and opened the door for hemp-derived THC beverages to flood mainstream channels. Then came **the Minnesota effect**, where lawmakers accidentally greenlit hemp THC seltzers in bars, liquor stores and restaurants. **The state racked up over $200 million in drink sales almost overnight, and other states took notice.** [Minnesota bar](https://www.thedrinksbusiness.com/2026/02/craft-brewers-turn-to-thc-drinks-for-growth-as-legal-uncertainty-looms/) “THC is not our entire business, but it has become an increasingly important component of it,” says Ryan Bandy, chief business officer at Indeed Brewing Company in Minneapolis. **“I’d say it is responsible for about 15% to 20% of our volume and delivers 25% to 35% of our revenue.** [Minnesota bar](https://www.marketwatchmag.com/the-cannabis-drinks/) Earl Giles CEO Nick Kosevich calls cannabis drinks the most exciting new beverage segment in decades and says they’re showing the “most insane growth” he’s seen across the distillery and restaurant business......At Earl Giles restaurant, alcohol comprises 75% of beverage sales and **THC drinks make up 20%,** with non-alcohol drinks holding the remaining 5%. [Ohio bar](https://www.wkyc.com/article/news/local/ohio/ohio-bars-breweries-impact-state-law-bans-sale-thc-seltzers-hemp-weed-drink-money-alcohol/95-099e4445-d966-4232-af29-c603ccff34b2) At Jukebox in Ohio City, **THC seltzers make up nearly 10% of all sales**. [Florida bar](https://www.sun-sentinel.com/2026/04/23/buzzkill-thc-drinks-are-exploding-at-south-florida-bars-breweries-and-restaurants-but-will-they-last/) Which is why using Funky Buddha’s 115,000-square-foot warehouse for **co-packing hemp-derived THC drinks is a lucrative side hustle** [Florida liquor](https://ecrm.marketgate.com/Blog/2025/09/THC-Beverage-Consumers-Are-a-Surprisingly-Diverse-Group-at-This-Florida-Restaurant-Chain) In just six months, THC beverages have shot to 3 percent of sales at the Clearwater Beach liquor store. “That may not sound huge, but **going from zero to 3 percent that quickly is a big deal**,” Sousa says. “And we’re just getting started.” [Willie Nelson Brand sales](https://www.foodbev.com/news/willie-nelson-s-thc-beverage-brand-raises-15-million-to-fuel-us-retail-expansion) Since launching less than a year ago, the brand said it has sold more than 400,000 bottles online, achieving a projected **annualized revenue run rate of roughly $80 million**. The funding will support a retail expansion in 2026, **leveraging JuneShine Brands.....established three-tier distribution network.**

GeoLogic23

>It's also an extremely capital intensive production process compared to pre-rolls ,vapes, flower or edibles. Yes exactly, it's a much higher barrier to entry. That's why I'm saying that companies that already have beverage distribution and manufacturing are at an advantage. You can't have just anybody jump in and compete with you. There is the whole [three-tier system](https://en.wikipedia.org/wiki/Three-tier_system_(alcohol_distribution)) that gatekeeps new adult beverage brands. So many people can grow THC flower and get vapes made. That's why **prices keep racing to the bottom** in every new cannabis market. We've seen this happen for many years in many markets. What you need to do is go back and look at recent numbers being reported by various alcohol retailers and bars in the US. THC beverages are [significant percentage](https://www.reddit.com/r/weedstocks/comments/1t4atd8/comment/ok3vikk/?utm_source=share&utm_medium=web3x&utm_name=web3xcss&utm_term=1&utm_content=share_button) of sales for those that sell them, and they are the fastest growing segment in THC products for a while now. It's funny you say Canopy is just using beverages as a distraction, because I don't feel like Canopy talks about them that much. I'm the one whose talking about them. Canopy didn't mention beverages at all in their business highlights in this press release.

GeoLogic23

I feel like we are close, but never underestimate the government's ability to drag their feet. Drinks have definitely proven they sell in regular retail, and there's a current fight over American liquor in Canada. It seems like such an obvious move to take some of that American liquor shelf space and dedicate it to home grown Canadian THC drinks.

i-love-you-sm

I’d have to imagine we’re getting closer to Canada allowing THC beverage sales in bars, liquor stores, some retail shops. TLRY controls about 45% of the market for THC beverages in Canada.

GeoLogic23

Canada beverages still to this day are only sold in dispensaries. The beverage boom in the USA is happening in places that sell THC beverages alongside alcohol. Which is why companies with alcohol distribution networks are at an advantage, should the hemp beverage market be regulated. Look up what the three tier system is for alcohol. It's not something where you can just create a product and instantly start selling it everywhere. You need lots of distributor relationships. Tilray has a huge percentage of the Canadian beverage market. They are just hoping they'll be able to sell them to regular consumers at some point instead of just dispensary consumers.

skyplt29

This is far more significant than what most may think. So many people I know who go on a diet stop drinking alcohol, but miss it. A lower THC beverage that affords on to take the edge off without putting the pounds on has huge potential. I would venture to think the alcohol industry sees the writing on the wall.

GeoLogic23

Yes they are **significantly** lower calories because alcohol adds calories but THC does not. Another reason this market is targeting the health conscious consumer, and doing well with women. Also depending on your tastes, but i find it much easier to cover up the taste of THC compared to alcohol. So they need less sugar and stuff to make better tasting drinks.

skyplt29

Geo! How dare you say anything remotely positive about an LP. This will indeed earn you some FoodCooker wrath. I can't be bothered to logout to look. Me? I am still holding onto my tulip bulbs in the hope they will be worth thousands in a few months. Also have some South Seas tea that I am furious about it not being worth more. Seriously, if this hemp beverage thing actually works out (I read your post on that, thanks for sharing the paywalled article) those companies with established distribution channels will do well. I am firmly in the lower THC content group. I am not one who drinks to get drunk...just to take off a bit of the edge and relax. I would think low THC drinks will be a great crossover for those who enjoy a casual social drink after work. If hemp beverages can actually be served in bars...it could be massive. BTW, do you happen to know if the calorie count on hemp beverages is less than alcohol?

jmu_alumni

I don’t understand how a 1 month delay could help the broader THC framework knowing that is gets banned one month later. But I also don’t think the white house is lying to the senators…. So I just don’t understand the reasoning. I do think elections may play a role, but I would have thought that would be a reason provided

Kbarbs4421

> Trump laid out the argument to Sen. Ted Budd (R-N.C.) for why the White House supports a provision in the stopgap funding bill that would delay the ban by about a month .... The White House is working on a broader framework addressing THC products for medicinal uses, and officials are concerned the ban could complicate those plans. .... White House liaison James Braid .... committed to no further delays — beyond the one included in the short-term funding measure.

GeoLogic23

Here's what I have off the top of my head. Maybe missing some. Tier 1 (heavy focus/interest) - RYM, Tilray, Canopy, Jones Soda, Boston Beer Tier 2 (smaller part of business) - Organigram, SNDL, Trulieve, Curaleaf Tier 3 (micro caps) - cbdMD, LFTD Partners Then there are also other alcohol companies with a history in cannabis beverages. Constellation, Molson, etc.. Some have suggested that if the hemp ban does happen, it's basically just a short term ban so big alcohol can swoop in and buy up the good brands. Then there are companies like Alimentation Couche-Tard (Circle K) and Target that are retailers moving into THC beverages. Circle K would be much more affected by THC beverages gaining popularity though. Also SNDL would benefit if Canadian liquor stores were allowed to sell THC beverages.

Tiaan

>An amendment to a Senate spending bill that would remove a delay to the federal ban on most hemp-derived THC products has been ruled germane by the parliamentarian, meaning it can pass with a simple majority. It could receive a vote as soon as tomorrow. per MJHerald. Not looking good for hemp

trent_upscale

If you're reading this and you're high on THC, your family hates you because you went balls deep in HRTZ put debt spreads

GeoLogic23

# From Dispensaries To The Mainstream That familiarity is beginning to extend beyond the dispensary counter. Earlier this summer, ayrloom became the [first hemp-derived THC beverage brand with an official presence at Governors Ball](https://www.bevnet.com/pr/2026/07/22/ayrloom-sees-tremendous-growth-across-the-business), where it distributed thousands of low-dose beverages throughout the festival. For Brennan, the activation demonstrated that cannabis beverages can fit naturally into mainstream social occasions. Cuccurullo believes long-term success will depend on something simpler than potency. "Ultimately, normalization isn't about encouraging more consumption," she says. "It's about helping adults make informed choices and giving them products that consistently deliver the experience they expect." # The Bottom Line The legal cannabis industry spent its first decade proving it could build stronger products. Its second decade may be defined by building products that millions more adults feel comfortable trying for the first time.